Education
About Us
Working with TipRanks
Follow Us
Charmacy Pharmaceutical Co., Ltd. Class H (HK:2289)
:2289
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 4.40B | ¥ 4.18B | ¥ 3.79B | ¥ 3.99B | ¥ 3.49B |
| Gross Profit | ¥ 292.74M | ¥ 268.61M | ¥ 234.12M | ¥ 237.40M | ¥ 220.65M |
| Operating Income | ¥ 66.19M | ¥ 93.49M | ¥ 74.42M | ¥ 88.08M | ¥ 85.20M |
| EBITDA | ¥ 136.92M | ¥ 119.19M | ¥ 107.55M | ¥ 111.03M | ¥ 110.15M |
| Net Income | ¥ 51.34M | ¥ 90.47M | ¥ 23.15M | ¥ 40.56M | ¥ 40.15M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 644.76M | ¥ 503.81M | ¥ 641.76M | ¥ 602.02M | ¥ 517.53M |
| Total Assets | ¥ 3.25B | ¥ 2.87B | ¥ 2.76B | ¥ 2.80B | ¥ 2.50B |
| Total Debt | ¥ 1.56B | ¥ 1.41B | ¥ 1.61B | ¥ 1.64B | ¥ 1.51B |
| Net Debt | ¥ 927.26M | ¥ 913.11M | ¥ 981.75M | ¥ 1.05B | ¥ 999.34M |
| Total Liabilities | ¥ 2.65B | ¥ 2.27B | ¥ 2.26B | ¥ 2.30B | ¥ 2.02B |
| Stockholders' Equity | ¥ 597.81M | ¥ 594.48M | ¥ 504.10M | ¥ 502.55M | ¥ 483.59M |
| Cash Flow | |||||
| Free Cash Flow | - | ¥ 35.46M | ¥ -44.58M | ¥ 79.10M | ¥ -69.88M |
| Operating Cash Flow | - | ¥ 44.05M | ¥ -19.54M | ¥ 131.08M | ¥ 4.02M |
| Investing Cash Flow | ¥ 39.34M | ¥ 71.76M | ¥ -24.40M | ¥ -54.78M | ¥ -73.74M |
| Financing Cash Flow | ¥ 101.26M | ¥ -191.21M | ¥ 74.40M | ¥ -2.68M | ¥ 54.13M |